Skip to content
Disclosery

Vivo Capital, LLC

Follow

13F filer, CIK 1674712, Palo Alto, CA

Vivo Capital, LLC reported $1,202,954,264 across 46 holdings for the quarter ended 2026-03-31, in a 13F-HR/A filed 2026-05-20. Its ten largest share positions make up 59.33% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR/A 0001213900-26-059247

Period
2026-03-31
Reported value
$1.2B
Holdings
46
Top 10 weight
59.33%
New
8
Sold out
9

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ERASadded+2,878,052$46.6M
FTHnew+722,020$22.8M
AVBPnew+885,916$20.4M
MANEnew+300,000$18.9M
ANTXnew+3,153,640$10.8M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
TERNreduced-4,012,510-$212M
CDTXexited-956,670-$211M
COGTreduced-1,976,693-$76.1M
AVADEL PHARMACEUTICALSexited-2,684,109-$57.8M
ZBIOexited-853,495-$31M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2026

Share positions as resolved from 13F-HR/A 0001213900-26-059247, largest first. % of portfolio is the value over $1,202,954,264, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 6,756,756 shares; 2024Q4: 6,756,756 shares; 2025Q1: 6,756,756 shares; 2025Q2: 6,756,756 shares; 2025Q3: 9,273,428 shares; 2025Q4: 9,273,428 shares; 2026Q1: 12,151,480 shares 12,151,480$197M16.34%+2,878,052Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 167,600 shares; 2025Q3: 198,895 shares; 2025Q4: 328,895 shares; 2026Q1: 338,895 shares 338,895$109M9.08%+10,000Timeline
TERNTERNS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 6,895,746 shares; 2024Q4: 6,895,746 shares; 2025Q1: 6,895,746 shares; 2025Q2: 6,895,746 shares; 2025Q3: 6,895,746 shares; 2025Q4: 5,346,928 shares; 2026Q1: 1,334,418 shares 1,334,418$70.4M5.85%-4,012,510Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,612,903 shares; 2024Q4: 3,487,903 shares; 2025Q1: 3,487,903 shares; 2025Q2: 4,487,903 shares; 2025Q3: 5,094,668 shares; 2025Q4: 5,094,668 shares; 2026Q1: 5,094,668 shares 5,094,668$60.8M5.05%0Timeline
DBVTDBV TECHNOLOGIES S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 32,020 shares; 2025Q1: not reported; 2025Q2: 1,054,506 shares; 2025Q3: 1,054,506 shares; 2025Q4: 2,461,626 shares; 2026Q1: 2,667,569 shares 2,667,569$55.7M4.63%+205,943Timeline
CMPXCOMPASS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,556,023 shares; 2024Q4: 3,556,023 shares; 2025Q1: 3,556,023 shares; 2025Q2: 6,043,466 shares; 2025Q3: 9,545,466 shares; 2025Q4: 9,545,466 shares; 2026Q1: 9,545,466 shares 9,545,466$50.5M4.2%0Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 600,000 shares; 2025Q3: 776,699 shares; 2025Q4: 2,154,780 shares; 2026Q1: 2,154,780 shares 2,154,780$45.1M3.75%0Timeline
SABSSAB BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 11,420,000 shares; 2025Q4: 11,420,000 shares; 2026Q1: 11,420,000 shares 11,420,000$43.7M3.64%0Timeline
CRVSCORVUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,497,268 shares; 2024Q4: 2,234,566 shares; 2025Q1: 2,234,566 shares; 2025Q2: 2,234,566 shares; 2025Q3: 2,234,566 shares; 2025Q4: 2,234,566 shares; 2026Q1: 2,805,816 shares 2,805,816$41M3.41%+571,250Timeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 251,572 shares; 2025Q1: 251,572 shares; 2025Q2: 251,572 shares; 2025Q3: 501,617 shares; 2025Q4: 501,617 shares; 2026Q1: 557,172 shares 557,172$40.7M3.38%+55,555Timeline
SVASINOVAC BIOTECH LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 11,800,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 5,903,000 shares; 2025Q3: 5,903,000 shares; 2025Q4: 5,903,000 shares; 2026Q1: 5,903,000 shares 5,903,000$38.2M3.17%0Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 353,998 shares; 2025Q4: 353,998 shares; 2026Q1: 353,998 shares 353,998$29.7M2.47%0Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,114,960 shares; 2024Q4: 1,114,960 shares; 2025Q1: 1,114,960 shares; 2025Q2: 1,114,960 shares; 2025Q3: 2,614,960 shares; 2025Q4: 2,614,960 shares; 2026Q1: 1,557,466 shares 1,557,466$28.2M2.35%-1,057,494Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 359,305 shares; 2025Q4: 359,305 shares; 2026Q1: 239,539 shares 239,539$26.7M2.22%-119,766Timeline
NERVMINERVA NEUROSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,322,747 shares; 2026Q1: 4,322,747 shares 4,322,747$26M2.17%0Timeline
ACRSACLARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 8,888,888 shares; 2025Q1: 8,888,888 shares; 2025Q2: 8,888,888 shares; 2025Q3: 8,888,888 shares; 2025Q4: 8,888,888 shares; 2026Q1: 6,666,666 shares 6,666,666$25M2.08%-2,222,222Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,277,818 shares; 2024Q4: 1,277,818 shares; 2025Q1: 2,080,450 shares; 2025Q2: 3,126,604 shares; 2025Q3: 3,126,604 shares; 2025Q4: 2,118,384 shares; 2026Q1: 1,848,786 shares 1,848,786$23.4M1.95%-269,598Timeline
ANROALTO NEUROSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,035,551 shares; 2026Q1: 1,035,551 shares 1,035,551$23.3M1.94%0Timeline
FTHFAETH THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 722,020 shares 722,020$22.8M1.89%newTimeline
AVBPARRIVENT BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 885,916 shares 885,916$20.4M1.7%newTimeline
LBRXLB PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 800,000 shares; 2025Q4: 800,000 shares; 2026Q1: 800,000 shares 800,000$19.7M1.64%0Timeline
MANEVERADERMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 300,000 shares 300,000$18.9M1.57%newTimeline
CAMPCAMP4 THERAPEUTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 3,921,568 shares; 2025Q4: 4,246,568 shares; 2026Q1: 4,246,568 shares 4,246,568$18.7M1.56%0Timeline
MLTXMOONLAKE IMMUNOTHERAPEUTICSQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,000,000 shares; 2026Q1: 1,000,000 shares 1,000,000$18.6M1.55%0Timeline
DSGNDESIGN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,612,903 shares; 2026Q1: 1,612,903 shares 1,612,903$17.2M1.43%0Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,122,471 shares; 2024Q4: 1,122,471 shares; 2025Q1: 1,122,471 shares; 2025Q2: 1,122,471 shares; 2025Q3: 2,789,137 shares; 2025Q4: 2,398,993 shares; 2026Q1: 422,300 shares 422,300$16.3M1.35%-1,976,693Timeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 27,225,292 shares; 2024Q4: 27,225,292 shares; 2025Q1: 27,225,292 shares; 2025Q2: 27,225,292 shares; 2025Q3: 27,225,292 shares; 2025Q4: 27,225,292 shares; 2026Q1: 8,671,797 shares 8,671,797$12.9M1.07%-18,553,495Timeline
UNCYUNICYCIVE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,137,015 shares; 2025Q3: 1,789,916 shares; 2025Q4: 1,789,916 shares; 2026Q1: 1,789,916 shares 1,789,916$11.8M0.98%0Timeline
ANTXAN2 THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,153,640 shares 3,153,640$10.8M0.9%newTimeline
OLMAOLEMA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,505,862 shares; 2024Q4: 1,505,862 shares; 2025Q1: 1,505,862 shares; 2025Q2: 1,505,862 shares; 2025Q3: 1,505,862 shares; 2025Q4: 671,843 shares; 2026Q1: 671,843 shares 671,843$10M0.83%0Timeline
SLNOSOLENO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 6,291,851 shares; 2024Q4: 6,291,851 shares; 2025Q1: 4,458,294 shares; 2025Q2: 3,958,294 shares; 2025Q3: 2,278,203 shares; 2025Q4: 894,909 shares; 2026Q1: 294,909 shares 294,909$9.87M0.82%-600,000Timeline
EPRXEUPRAXIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,350,000 shares; 2025Q4: 1,350,000 shares; 2026Q1: 1,350,000 shares 1,350,000$9.77M0.81%0Timeline
OKURONKURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,927,710 shares 1,927,710$7.98M0.66%newTimeline
SRZNSURROZEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 260,000 shares; 2025Q2: 260,000 shares; 2025Q3: 260,000 shares; 2025Q4: 260,000 shares; 2026Q1: 260,000 shares 260,000$7.57M0.63%0Timeline
ALXOALX ONCOLOGY HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 4,034,522 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,184,713 shares 3,184,713$6.39M0.53%newTimeline
MNPRMONOPAR THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 90,500 shares; 2025Q4: 90,500 shares; 2026Q1: 90,500 shares 90,500$4.96M0.41%0Timeline
MSLESATELLOS BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 813,666 shares 813,666$4.58M0.38%newTimeline
PEPGPEPGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 2,325,000 shares; 2025Q4: 2,325,000 shares; 2026Q1: 2,325,000 shares 2,325,000$4.12M0.34%0Timeline
SERASERA PROGNOSTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,650,440 shares; 2024Q4: 1,650,440 shares; 2025Q1: 1,650,440 shares; 2025Q2: 1,650,440 shares; 2025Q3: 1,650,440 shares; 2025Q4: 1,650,440 shares; 2026Q1: 1,650,440 shares 1,650,440$3.35M0.28%0Timeline
TENXTENAX THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 208,333 shares; 2024Q4: 208,333 shares; 2025Q1: 208,333 shares; 2025Q2: 208,333 shares; 2025Q3: 208,333 shares; 2025Q4: 208,333 shares; 2026Q1: 208,333 shares 208,333$3.33M0.28%0Timeline
VRDNVIRIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,678,207 shares; 2024Q4: 982,576 shares; 2025Q1: 982,576 shares; 2025Q2: 982,576 shares; 2025Q3: 982,576 shares; 2025Q4: 982,576 shares; 2026Q1: 166,288 shares 166,288$3.25M0.27%-816,288Timeline
TILINSTIL BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 624,339 shares; 2024Q4: 585,485 shares; 2025Q1: 585,485 shares; 2025Q2: 292,743 shares; 2025Q3: 292,743 shares; 2025Q4: 292,743 shares; 2026Q1: 292,743 shares 292,743$2.41M0.2%0Timeline
KTTAPASITHEA THERAPEUTICS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,100,000 shares; 2026Q1: 2,100,000 shares 2,100,000$1.56M0.13%0Timeline
CMPSCOMPASS PATHWAYS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,608,000 shares; 2024Q4: 1,608,000 shares; 2025Q1: 3,362,385 shares; 2025Q2: 3,362,385 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 200,000 shares 200,000$1.11M0.09%newTimeline
BOLTBOLT BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 176,064 shares; 2025Q3: 176,064 shares; 2025Q4: 72,414 shares; 2026Q1: 72,414 shares 72,414$293K0.02%0Timeline
DTILPRECISION BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 4,675 shares; 2024Q4: 4,675 shares; 2025Q1: 4,675 shares; 2025Q2: 4,675 shares; 2025Q3: 4,675 shares; 2025Q4: 4,675 shares; 2026Q1: 4,675 shares 4,675$25.7K<0.01%0Timeline

Sold out in Q1 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CDTXCIDARA THERAPEUTICS INC956,670$211Mshares
AVADEL PHARMACEUTICALSAVADEL PHARMACEUTICALS2,684,109$57.8Mshares
ZBIOZENAS BIOPHARMA INC853,495$31Mshares
CTMXCYTOMX THERAPEUTICS INC.2,884,615$12.3Mshares
ABEOABEONA THERAPEUTICS INC1,842,751$9.71Mshares
VSTMVERASTEM INC1,106,524$8.54Mshares
SLNSILENCE THERAPEUTICS PLC1,105,454$6.72Mshares
PALIPALISADE BIO INC2,293,578$5.39Mshares
ENGNWENGENE HOLDINGS INC285,046$844Kshares

How Q1 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001213900-26-057929 superseded2026-05-15acceptance time not in the bulk data set
13F-HR/A 0001213900-26-059247 baserestatement2026-05-20acceptance time not in the bulk data set